Stacking the deck against ovarian cancer

Nearly 70 percent of ovarian cancer cases are detected after metastasis, which is the development of secondary malignant growths distant from the primary site of cancer. Understanding ovarian cancer metastasis is a research focus of M. Sharon Stack, the Ann F. Dunne & Elizabeth Riley Director of the Harper Cancer Research Institute (HCRI) and Kleiderer-Pezold Professor of Chemistry and Biochemistry at the University of Notre Dame.